Tanuj Keshav

- Financial risk management of Bayer subsidiaries including treasury planning, liquidity and foreign exchange exposure management, subsidiary financing, and capital structure steering - Identified and executed cash/earnings repatriation measures worldwide enabling annual dividend distribution by Bayer AG (FY2019: 2.75bn EUR) to external shareholders in line with dividend policy - Functional expert in minority R&D equity investments, M&A, Divestitures, and Business Development & Licensing deals

- Covestro Carve-Out: Led carve-out activities for Procurement and Legal functions supporting a ~3.4bn EUR carved-out NAFTA business, resulting in set-up of stand-alone organizations pre-IPO while mitigating dis-synergies - Project New Bayer Reorganization: Advised US Health Safety & Environment (HSE) project lead in developing functional strategy and organizational redesign of HSE across 16 production and ~90 R&D sites, distribution, warehousing and packaging facilities covering 100+ HSE employees

- Led key initiatives related to financial analysis, spend analysis, market intelligence, reporting and spend benchmarking in Indirect and SG&A areas - Implemented Supplier Management framework which included supplier segmentation, and differentiated risk/performance/contract management approaches for strategic, key and base suppliers in the indirect spend areas (~800m USD) that led to enhanced spend management and contract compliance

- Performed financial and analytical analysis, financial modeling and sensitivity analysis (buy/lease, make/buy, asset utilization studies, capital investment, should-cost, total cost of ownership) supporting business decisions and commercial negotiations - Litigation spend management - Led supplier selection/sourcing initiative to execute an engineering alliance relationship for Bayer's Engineering and Technology arm to successfully manage CapEx/OpEx projects

- Responsible for ~50m INR sales, receivables (DSO) and profitability (contribution margin) of the portfolio - Led business development activities for laboratory solutions (six brands) in Western India and managed relationships with key distributors and end customers

- Controlled and supervised production activities in the manufacture of various grades of carbon black - Evaluated capital investment projects based on key financial metrics like ROI, NPV, IRR and payback period

Valuation, Derivatives, Capital Markets, Fixed income Securities, Strategy